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Calcium phosphate (CaP) ceramics are of interest in bone substitution due to their good biocompatibility and 
bioresorbability. Currently certain CaPs on the market are loaded with antibiotics in order to prevent infections but further 
control is needed over the antibiotic release patterns. Cold plasmas have emerged as useful means of modifying the 
interactions with drugs through surface modification of ie. polymer materials.  In this work we explore the possibility of using 
atmospheric pressure plasma as a tool for the surface modification of these CaP materials with newly populated bonds and 
charges, with views on enabling higher loading and controlled drug release.  Herein the surface modification of -tricalcium 
phosphate ceramics is investigated using atmospheric pressure Helium plasma jet as a tool for tuning the controlled release 
of the antibiotic Doxycycline hyclate, employed as a drug model. The surface chemistry is tailored mainly by plasma jet 
surface interaction with increasing the O/C ratio without changes in topography as well as by build-up of surface charge. 
With this surface tailoring it is demonstrated that atmospheric plasma jet is a new promising tool that leads to design of 
control for drug release from bioceramic matrices. 
Introduction 
In the field of bone regeneration, there are several classes of synthetic bone grafting biomaterials wherein calcium phosphate 
bioceramics play a significant role due to their excellent biocompatibility and resorbability.[1] Bone grafting procedures are often 
performed following bone infections such as osteomyelitis or periodontitis which result in bone loss. The local adminstration of 
antibiotics in combination with a calcium phosphate delivery matrix with osteoconductive or osteoinductive properties may 
allow combating against the infection while simultaneously promoting bone regeneration. In this approach, it is essential not 
only to ensure drug access to the specific bone site, but also to maintain the drug concentration released within the 
therapeutical range for long periods of time.[2] Therefore, the drug elution kinetics must be carefully controlled.  
Calcium phosphate ceramics, which are prepared at high temperatures, must be loaded with drugs commonly by impregnation 
techniques using highly concentrated solutions. In those materials, the kinetics of release is mainly ruled by the diffusion 
process, through their structure. However it is not easy to modify such drug release patterns by tailoring the textural properties 
(surface area, pore size, pore volume, pore shapes, etc.) of ceramic materials treated at high temperatures with wet chemical 
treatments.[3]  Whereas herein we investigate a new strategy to modify surfaces and change the drug release patterns of Calcium 
Phosphate ceramics with gas discharges. Within the proposed novel approach we evaluate the surface modification of calcium 
phosphate ceramics with an atmospheric pressure plasma jet (APPJ) for the design of controlled release matrices which would 
have slower elution patterns. APPJ have small dimensions and could easily be implemented in a surgical room. Thus, this 
treatment could be compatible with the prophylactic strategy often used by surgeons to prevent post-surgical infections which 
consists in soaking the synthetic bone graft in an antibiotic solution right before implantation.  
Generally, atmospheric pressure plasmas are an emerging technology in the medical field with varied applications ranging from 
sterilization of medical equipment, surface modification of biomaterials, to treatment of wounds and tissues.[4] The biggest 
advantage of this technology is treatment of surfaces in ambient air at open atmosphere, which requires neither expensive 
vacuum equipment and systems nor complicated procedures.  
Low pressure plasmas have shown that it is possible to introduce new reactive groups on biomaterials through functionalization 
or plasma polymerization to obtain the modulation of release of active principles from either polymeric matrices or from model 
surfaces.[5] To the best of our knowledge, no work has been performed on the application of atmospheric pressure plasma jets to 
surface modifications of drug release properties from CaP materials.  
For this reason, we investigated and evaluated the physic-chemical effects of an APPJ using Helium as carrier gas on the surface 
properties of microporous β-Tricalcium Phosphate (β-TCP) ceramics. The plasma treated microporous β-TCP ceramics have been 
loaded with Doxycycline hyclate (Doxy), an antibiotic with strong activity against periodontal pathogens and with broad-
spectrum antibiotic effects.[6] The results of the surface modification were also assessed on the in vitro release of Doxy from the 
ceramics.  
 
 
  
Results 
The atmospheric plasma employed in this work projects a very thin jet (of 1-2 mm diameter of visible light emission) towards the 
sample (Figures 1a and 1b). To investigate whether the parameters selected (distance to the sample, gas flow and power) would 
be sufficient to uniformly treat the 15 mm diameter surface of the β-TCP discs, static contact angle was envisaged as an 
adequate technique as it allows measuring different points of the same sample. However, the microporous structure of the β-
TCP ceramics, as well as its inherent hydrophilic properties did not allow measurement of the contact angle due to immediate 
water absorption by the material. Nevertheless, given the small dimensions of the plasma jet, it was relevant to investigate 
whether the treatment performed was uniform on the whole treated surface. Therefore, to have an indication of the surface 
uniformity of the atmospheric plasma treatment, PLLA films were used as model surface and the contact angle was measured at 
different distances from the center of the sample where the jet was directly applied. As shown in Figure 1c, the atmospheric 
plasma jet treatment improved wettability by decreasing contact angle more than 20º in the center of the sample where 
incidence of the jet was direct. Contact angle progressively increased with the distance to the center of the sample where the jet 
falls upon until 5 cm of distance where the plasma species are no longer created in abundant quantities. 
 
 
Figure 1. APPJ and uniformity of treatment. Schematic of the experimental set up with APPJ a), photograph of the impinging jet 
on the β-TCP discs b), and evaluation of static contact angle on PLLA films as a function of the distance to the plasma jet (He, 20 
slm, 10 min) c). 
 
 
 
 
Table 1.  Elemental composition and atomic ratio of β-TCP discs untreated and treated with He APPJ for different times.   
 
 
Effects of plasma jet on β-TCP 
In the first place, the effects of plasma on the surface topography of β-TCP ceramics were evaluated by Scanning Electron 
Microscopy (Figure 2). According to the images, the samples are highly porous, and present the typical structure of sintered 
ceramics. In some of the images some small particles were observed which was attributed to incomplete sintering of the 
samples. No etching or any other topographical effects were observed due to the plasma treatment.   
Given the relevance of the chemical composition of the samples with regard to latter drug loading, the material was analyzed by 
IR-ATR and X-ray diffraction (Figure 3). On the one hand, IR-ATR of powders obtained from the surface of the disks allowed 
determining the presence of the phosphate bands characteristic of β-TCP, as all the bands obtained corresponded to phosphate 
 Elemental composition (%) Atomic ratio 
 C O Ca P O/C Ca/P 
UT 37.40 40.60 12.90 9.10 1.09 1.42 
1 min 28.41 45.66 14.03 10.21 1.61 1.37 
5 min 22.97 48.58 14.27 9.68 2.11 1.47 
10 min 19.12 49.74 14.90 10.63 2.60 1.40 
20 min 12.88 51.11 13.87 9.65 3.97 1.44 
 vibrations, where the wide bands correspond to ν3 stretching (969–1155 cm
-1) and ν4 bending (540–640 cm
-1).[8] On the other 
hand, all XRD peaks did correspond to highly crystalline β-TCP.   
The surface chemistry of the ceramics was studied by X-ray Photoelectron Spectroscopy (Table 1). The presence of C on the 
surface of the sample can be associated to contamination by adsorbed hydrocarbons. The treatment with the atmospheric 
plasma needle using He led to a progressive increase in oxygen contents with longer treatment times. The Ca/P ratio was slightly 
lower than the theoretical one for β-TCP (Ca3(PO4)2, Ca/P ratio 1.5), and remained unaltered after the APPJ plasma treatment 
[9].  
 
 
Figure 2. Scanning Electron Micrographs of β-TCP discs untreated or treated with atmospheric plasma jet for different times at 
two different magnifications. 
 
 
Figure 3. IR-ATR spectra of powders obtained from the surface of untreated β-TCP (a) and X-ray diffractogram of untreated β-TCP 
disks.  
Figure 4 presents the deconvolution of the high resolution C1s and O1s XPS spectra of the ceramic surface before and APPJ 
treatment (20 minutes). The atomic percentages of the carbon and oxygen species are summarized in Table 2. Initially, the C1s 
present on the surface can be ascribed to the presence of adventitious carbon contamination. The O1s peak decomposition 
suggests that the contaminant possesses hydroxyl groups. With the APPJ treatment the hydrocarbons are progressively 
eliminated, and at long plasma treatment times there is some extent of functionalization of the hydrocarbons with oxidized 
moieties such as alcohols, ketones, and carboxyl groups. 
Positive charging was measured on the surface of β-TCP immediately after APPJ treatment (Figure 5). Interestingly, short APPJ 
treatment times led to charge build up, which seemed to progressively translate inwards the porous structure of the material 
with increasing treatment times until full surface charge saturation was achieved.  This was also observed in ageing graphs 
(Figures 5b and 5c) where the β-TCP ceramics treated for short time showed a decrease of the surface charge with time after 
treatment, while the samples treated for longer times (e.g. 10 min) tended to maintain surface charges for longer times.  
 
 
  
 
 
Figure 4. Example of the deconvolution of C1s peak of β-TCP samples (a) untreated and (b) APPJ treated for 20 minutes and of 
the deconvolution of O1s peak of β -TCP samples (c) untreated and (d) APPJ treated for 20 minutes.  
 
 
 
 
Table 2. Decomposition of C1s and O1s peaks of β-TCP discs untreated and treated with He APPJ for different times. 
 Relative chemical composition (%) 
 C1s  O1s 
 284.76 eV  286.09 eV  287.09 eV 288.79 eV 531.20 eV 532.90 eV 
 C-C C-O C=O COO OH- P-O-P 
UT 94.25 0 2.45 3.30 92.82 7.17 
1 min 81.89 0 6.19 11.92 86.96 13.04 
5 min 90.29 0 5.42 4.29 83.44 16.56 
10 min 63.43 16.86 9.13 10.59 76.63 23.37 
20 min 66.37 17.45 9.49 6.68 72.68 27.32 
 
 
2.2. Drug loading 
The hydrophilic nature of the β-TCP ceramics used here led to immediate water absorption. However, dropwise addition of a 
predetermined volume of aqueous Doxy solution on the samples led to immediate precipitation of the drug for the two 
concentrations assayed. Figure 6 shows the presence of Doxy crystals completely masking the structure of β-TCP and blocking 
the pores of the material, even after APPJ treatment. This impaired the absorption of the drug solution through the pores, so 
samples were allowed to dry until constant weight before the release experiments.  
 
 
 
 
 
 
 
 
 
 Figure 5. Surface charge of β-TCP at different treatment times with APPJ (a) and characteristic evolution of surface charge with 
time after APPJ treatment or so-called surface charge aging in β-TCP treated for 3 min (b) or 10 min (c). 
 
 
Figure 6. Surface of untreated β-TCP loaded with two different Doxy amounts (3.45 mg – left and 10 mg – center) and APPJ 
treated and loaded with 10 mg of Doxy at increasing magnifications (from top to bottom).  
2.3. Drug release 
In Figure 7, the cumulative drug percentage released from APPJ treated β-TCP loaded with two different Doxy concentrations 
along 24 h is presented. It can be observed that at both representative concentrations, the untreated samples were those 
displaying faster initial drug release, which led to higher antibiotic release percentages after 24 h. Whereas interestingly, all 
plasma treated samples displayed lower release percentages in the initial stages, this effect being typically more pronounced for 
samples treated for shorter times, regardless of the initial loading concentration tested.  
 
 
 
 
 
 
 
 
 
 
Figure 7. Accumulated Doxycycline release percentage of untreated and APPJ – treated β-TCP with two different drug loadings (a) 3.45 
mg/disc and (b) 10 mg/disc.  
  
 
 
Discussion 
 
Atmospheric pressure plasmas are increasingly gaining interest for their wide potential in the medical field [4a], and their use in 
the design of biomaterials with improved interactions with other molecules such as drugs or the biological environment is one of 
the most promising approaches. Herein, we designed a new drug delivery system based on the surface modification of 
β-TCP ceramics with an atmospheric pressure plasma. The atmospheric plasma was generated in an APPJ. 
 
 
which employed He as discharge gas. The He jet features many electrons, He metastables and ions, which are expected to 
activate the surface of the material directly in the streamer – surface coupling mode, which can create open bonds as well as 
vacancies in crystal structures.[10] However, it has to be taken into account that apart from the direct physical activation 
mechanism, some degree of chemical functionalisation might be taking place directly on the sample surface during plasma 
treatment as well. In fact, in the early afterglow of the plasma, a certain percentage of ambient air is mixing with the He jet and 
is generating radicals from air. This was already demonstrated in previous works [11], where optical emission spectroscopy was 
performed and excited He emission lines were observed along with other emission lines corresponding to neutral O atom, Hα, 
OH (A2 Σ – X2 Π), N2
+ first negative (C3 Πu – B
2 Σu
+) and N2 (B
3 Πu – B
3 Σu
+) second positive molecular band. Additionally, because of 
the diffusion of ambient air into the plasma and consequent collisions, the emission intensities of the He lines decrease as the 
plasma plume propagates into the surrounding air and the intensity of the other species increases.  
It has been shown using a model PLLA film that the treatments performed modify the whole diameter of the samples uniformly 
(Figure 1c). The contact angle measured tended to decrease with the distance from the jet, indicating that the active species 
react directly where the flow of the plasma is directed, and their density progressively decreases with distance. Although it is 
well known that different kinds of materials display different recombination probabilities towards the neutral radicals in the 
plasma phase [12], in general metallic materials are more reactive, showing higher recombination probabilities, while polymers 
and ceramics display lower reactivity, so the wettability results obtained with the PLLA film can be extrapolated to the β-TCP 
material employed here. It has been observed that wettability modifications on a flat surface are visible up to a radius of 5 cm 
from the center of the jet, so it can be considered that the samples used, with a radius of 0.75 cm are uniformly modified by the 
treatment performed here.  
The APPJ treatment performed was mild, avoiding any modification of the surface topography of the ceramics (Figure 2), or its 
Ca/P ratio that was found slightly lower than expected. In previous works this slightly lower Ca/P ratio detected was attributed to 
the fact that XPS analysis is restricted just to the outer surface of the material [13]. While plasma treatment of polymeric materials 
often proceeds through a time-dependent surface functionalisation with oxygen-containing groups (ie. carbonyl and carboxyl) 
[14], here cleaning effects seemed to be predominant (Tables 1 and 2). The O1s XPS high resolution peak decomposition 
suggested that the contaminant possesses acidic hydroxyl groups [15] which are progressively removed by the etching effect of 
the APPJ. Recent works with atmospheric pressure plasmas on hydroxyapatite ceramics [16] found a predominant cleaning effect 
with very hardly any oxygen functionalisation, as in the present study, while on biphasic hydroxyapatite/β-TCP ceramics [17] 
improved wettability was recorded with air atmospheric pressure plasmas with some extent of oxygen functionalisation, 
although it was not quantified.   
The β-TCP samples used in this study were highly porous (Figure 2) with pore sizes in the order of 0.5-2 µm. Untreated β-TCP 
displayed very good water wettability. Unexpectedly, when samples contacted the aqueous Doxy solutions used here, no 
absorption of the solution was observed. This could be attributed to immediate precipitation of Doxy crystals on the surface of 
the ceramics, which blocked the pores of the material and hampered absorption of the drug solution by the bioceramic (Figure 
6). This phenomenon can be ascribed to the interaction of Doxy with Calcium. In fact, Doxycycline is an antibiotic from the 
tetracycline family. It is known that tetracyclines display strong adsorption affinity for calcium phosphates [18], and in spite of the 
lower afﬁnity of Doxy with Ca compared to other tetracyclines, it was previously observed that its interaction slightly delayed the 
hydrolysis reaction in Calcium Phosphate Cements, affecting different properties.[19] Even though two different drug loads were 
tested, even the lowest led to a surface completely covered with Doxy crystals, so no penetration of the drug inside the material 
can be assumed. 
The results obtained regarding drug release are highly interesting and open a new pathway for the design of slower-releasing 
ceramic drug delivery systems. The release of Doxy from the materials took place in a two-step mechanism: an initial stage of 
burst release, which can be associated with the precipitated Doxy not directly bound to the surface. This was followed by a stage 
of slower release rate, where the stationary stage was not reached (Figure 7). The untreated samples with both starting Doxy 
concentrations reached around 60% of release in the first 3 h, while plasma treated samples had much lower release 
percentages in the same timeframe with values of 35-40% in the 5 min treated samples. Additionally, it was observed that the 
second release stage was delayed at least for 1 h, when the β-TCP samples had been treated with APPJ, although the release 
remains still too fast for the intended application.  
  
The charge conferred by the APPJ to the β-TCP surface may be related, at least in part, with the release results obtained: Liang et 
al. reported asymmetric charge distribution on the β-TCP surfaces with negatively charged areas near the O and positively 
charged ones in the vicinity of P and Ca atoms.[20] Following APPJ treatment positive charging was generated on the surface 
(Figure 5). This is in agreement with computational models [21] that demonstrated that in the interaction of a He APPJ with a 
dielectric surface, the flux of positive ions (O+2 in particular) to the surface is greater than that of negative ions (O
-
2). The strong 
electric field directed toward the dielectric surface causes the positive ions in the vicinity of the surface to migrate to the 
dielectric surface, where their positive charge is deposited on the surface of the dielectric. It seemed here that the positive 
charge diffused with time into the porous β-TCP structure until saturation was reached at treatment times above 10 min (Figure 
5).  
 
Figure 8. Proposed mechanism of interaction established between Doxycycline and the untreated β-TCP ceramics or APPJ 
treated ones at different treatment times. Exposure of O-groups by etching of surface contaminants and some degree of 
functionalisation progressively takes place with treatment time while the positive surface charge build-up is unstable at short 
treatment times while it is more permanent at longer times, thus compensating for the higher electronegativity of O-groups and 
hampering the interactions with Doxy. 
 
It can be speculated that the drug release patterns observed at different APPJ treatment times were a result of the combination 
of two effects: i) surface cleaning as shown by XPS (Tables 1 and 2) and ii) surface charge build up and stability. Both parameters 
may influence the spatial placement of the Doxy molecules adsorbed on the surface (Figure 8). As APPJ treatment exposes 
oxygen from β-TCP by removal of contaminants and by grafting of oxygen groups on the surface at short treatment times, and 
the charge created is rapidly generated, interaction of Doxy with the surface is enhanced, possibly through its amine groups, 
allowing higher packing of molecules on the surface. This improved interaction Doxy β-TCP may account for the slower drug 
release recorded. As APPJ treatment proceeds at longer times, the positive charges generated on the surface are more stable 
and compensate for the higher electronegativity conferred by the O-groups, tending to hamper the interactions with Doxy.  
It has been shown in other works that atmospheric pressure plasmas improve wettability of hydroxyapatite [16] and that on 
calcium phosphate scaffolds they can lead to improved osteoblast attachment and proliferation [17], so the combination of such 
features with the slower drug release obtained here can provide the bioceramics with highly attractive features. The strategy 
introduced in this work opens new perspectives for the control of drug release from ceramic matrices through the use of 
atmospheric plasmas.   
 
Conclusions 
In the present work the surface of β-TCP ceramics was conditioned with a He APPJ at different times, which enabled us to 
optimize and uniformly modify the chemistry of the β-TCP ceramics without altering their morphological features. Positive 
surface charge was generated, which was stable for long APPJ treatment times. The antibiotic Doxycycline was incorporated on 
the APPJ treated side of the materials, and it was demonstrated that the slower release of the antibiotic from the plasma treated 
ceramics could possibly be ascribed to the combination of higher exposure of O groups from the surface and surface charge build 
up and stability. With this novel approach it was possible to achieve more than 33% improvement in retaining drug release for 
optimized APPJ treated β-TCP with respect to untreated samples.  
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 Experimental Section  
5.1. Material synthesis 
Microporous β-TCP discs were produced by sintering calcium deficient hydroxyapatite (CDHA) discs (Ca/P = 1.5), obtained from a 
Calcium Phosphate Cement. The cement’s solid phase was β-TCP, obtained by heating in a furnace (Hobersal CNR-58) in air an 
appropriate mixture of calcium hydrogen phosphate (CaHPO4, Sigma Aldrich) and calcium carbonate (CaCO3, Sigma-Aldrich) for 
15 h at 1400ºC, followed by quenching in air. β-TCP powder was milled in an agate ball mill (Pulverisette 6, Fritsch GmbH) with 
10 balls (d=30mm) for 15 min at 450 rpm. The liquid phase employed to prepare the cement consisted of a 2.5% solution of 
Na2HPO4 in MilliQ water.  The powder phase was mixed with the liquid phase (L/P ratio of 0.35 ml/g) in a mortar for about 1 min 
and then transferred into disc moulds of 15 mm diameter x 2 mm height. Samples were allowed to set in water for 2 days to 
allow for its transformation into CDHA, before demoulding, drying and sintering. CDHA was transformed into β-TCP by sintering 
in air at 1110 ºC for 9 h, followed by slow cooling.  
 
5.2. Experimental methods 
5.2.1. Atmospheric Plasma Jet treatment 
An APPJ was created using He as plasma carrier gas in an end-filed jet design with electrode. The discharge electrode was a 
copper wire with a diameter of 0.1 mm inserted inside of a 1.2 mm inner diameter quartz capillary tube and was connected to a 
commercial high voltage power supply from Conrad Electronics (nominally 6 W power consumption). The discharge was 
operating with sinusoidal waveform at 23 kHz with (U) ~ 2 kV and (I) ~ 3 mA. The power input into discharge was about 1 W. 
Helium of purity 5.0 was leaked into the gas tube and then to ambient atmosphere at 15 slm through a Bronkhorst MassView 
flow controller. The samples were placed under the jet at equal distances of 25 mm from the tube opening and electrode end.  
5.2.2. Drug incorporation 
Antibiotic was incorporated to the β-TCP discs either untreated or plasma treated by addition of 100 µl of aqueous Doxy 
solutions to the top surface of the samples. The drug was placed on the plasma-treated side of the β-TCP discs and two different 
Doxy concentrations were used so as to obtain samples loaded with either 3.45 mg or with 10 mg of Doxy. Samples were allowed 
to dry at ambient temperature in a desiccator until constant weight.   
5.2.3. Drug release  
The drug release tests were performed according to the USP Pharmacopoeia Dissolution Test in a Paddle Dissolution Tester 
(Pharma Alliance, USA) with 8 amber vessels of 250 ml with 150 ml Phosphate Buffer Solution (PBS). β-TCP samples without drug 
were used as control. Stirring conditions were 150 rpm, temperature was set to 37 °C and 1 mL aliquots were withdrawn at 
predetermined times from the receptor compartment for spectroscopy analysis at λ=351 nm (TECAN, Infinite M200 Pro 
Microplate Reader). After each sample withdrawal, the same volume of fresh PBS was added to the receptor medium. The 
concentration of Doxy in the receptor solution was below 20 % of the saturation concentration (sink conditions) during the 
experiment.[22] Four replicates were studied of each sample (n=4). To precisely determine the Doxycycline concentration at each 
time point, three corrections were taken into account: (1) A total volume correction due to evaporation during the release 
experiment; (2) A correction to take into account the drug quantity withdrawn at each sampling; (3) A correction due to the 
antibiotic degradation in the experiment conditions. 
 
5.3. Characterization Techniques 
5.3.1. Wettability Contact Angle Measurements 
Static contact angle was determined on PLA films with an Oca15+ (Dataphysics) using water as wetting liquid and with SCA20 
software.  
5.3.2. Scanning Electron Microscopy 
The microstructure of the ceramics was imaged by Field Emission Scanning Electron Microscopy (SEM, JEOL JSM-7001F). Samples 
were C sputter coated prior to observation.  
5.3.3. X-Ray Photoelectron Spectroscopy 
The surface chemistry in upmost layers with penetration depth of 20 nm was investigated by X-ray photoelectron spectroscope 
(XPS) (TFA XPS Physical Electronics, Chanhassen, Minnesota, USA). The base pressure in the analysis chamber prior the 
measurements was approximately 6×10-8 Pa. We used Al Kα1,2 monochromatic source of X-ray light with energy of 1486.85 eV for 
sample analyses. The photoelectrons were detected with a hemispherical analyzer positioned at an angle of 45° with respect to 
the normal to the sample surface. The samples were analyzed over a 400 µm spot area. Each sample was analyzed at two 
different positions and the average composition was calculated. The relative error for XPS determination was about 0.5％. The 
XPS spectra were measured for an untreated and helium plasma treated samples. In addition to the wide energy range spectra, 
high-energy resolution spectra of characteristic peaks of C1s, O1s, N1s and Si2p elements are recorded through a narrow energy 
range. Spectra were referenced to the C1s peak, at 284.80 eV. Deconvolution, using Gaussian-Lorentzian fit was performed with 
MultiPak v7.3.1 software from Physical Electronics, supplied with the spectrometer. 
5.3.4. Infrared-Atenuated Total Reflectance 
Infrared with Attenuated Total Reflectance (IR-ATR) was performed on powder obtained from the surface of β-TCP discs and 
placed in a horizontal unit, covered by a germanium crystal.  
 5.3.5. X-Ray Diffraction  
Phase composition of powders obtained from the surface of β -TCP ceramics either untreated or APPJ treated was assessed by X-
ray powder diffraction (XRD, PANalytical, X’Pert PRO Alpha-1) by scanning in Bragg-Brentano geometry using CuKα radiation 
(λ=1.5406 A) . The experimental conditions used were: 1.5 h of scan time with 2θ scan step of 0.020 º and scan range between 4 
º and 100 º, with measuring time of 50 s per step. X-ray generator parameters: voltage 45 kV and intensity 40 mA. The diffraction 
patterns were compared with the Joint Committee on Powder Diffraction Standards for β-TCP (JCPDS No. 9–169).[23] 
5.3.6. Surface charge 
For electric field measurements a Trek (model 347, New York, USA) field meter with a proper high voltage probe was used. The 
field meter is capable of measuring ± 3 kV DC voltage with accuracy better than 0.05 % of full scale. The high voltage probe is 
circular with the diameter of 1.3 mm. A fast digital input card (NI USB 6009) was connected to the field meter via a BNC 
connector, which enabled to display and record voltage measurements in a time resolution of 50 ms. Surface charge experiments 
were done in a grounded box. The grounding was important to lower the electrical noise of the surroundings. Prior to conducting 
measurements, the field meter was zeroed using a grounded steel plate. The distance between the sample and the probe was 
1.1 cm. 
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